Showing results (151-160 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|December 21, 2019
Evolution of Cereblon-Mediated Protein Degradation as a Therapeutic ModalityPhilip P Chamberlain, Laura A D'Agostino, J Michael Ellis, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Novel Quinoline-based Ir(III) Complexes Exhibit High Antitumor Activity in Vitro and in VivoYan Yang, Yi-Dong Bin, Qi-Pin Qin, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Evaluating the Advantages of Using 3D-Enriched Fragments for Targeting BET BromodomainsJorden A Johnson, Christos A Nicolaou, Steven E Kirberger, et al.
ACS Medicinal Chemistry Letters|December 21, 2019
Structural Insights into Interaction Mechanisms of Alternative Piperazine-urea YEATS Domain Binders in MLLT1Xiaomin Ni, David Heidenreich, Thomas Christott, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune DiseasesHongjun Zhang, Blair T Lapointe, Neville Anthony, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Discovery of 4-Piperazine Isoquinoline Derivatives as Potent and Brain-Permeable Tau Prion Inhibitors with CDK8 ActivityJean-Marc M Grandjean, Alexander Y Jiu, John W West, et al.
ACS Medicinal Chemistry Letters|February 20, 2020
Discovery of Hydroxyamidine Based Inhibitors of IDO1 for Cancer Immunotherapy with Reduced Potential for GlucuronidationChristoph Steeneck, Olaf Kinzel, Simon Anderhub, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Biotransformation: Impact and Application of Metabolism in Drug DiscoveryJulia Shanu-Wilson, Liam Evans, Stephen Wrigley, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Antiferroptotic Activity of Phenothiazine Analogues: A Novel Therapeutic Strategy for Oxidative Stress Related DiseaseJun Liu, Indrajit Bandyopadhyay, Lei Zheng, et al.
ACS Medicinal Chemistry Letters|November 20, 2020
Hydrogen Peroxide Inducible JAK3 Covalent Inhibitor: Prodrug for the Treatment of RA with Enhanced Safety ProfileQichao Bao, Liangying Zhang, Nan Wang, et al.
Pageof 438